ATE480620T1 - Neue pgc-1-isoformen und deren verwendungen - Google Patents

Neue pgc-1-isoformen und deren verwendungen

Info

Publication number: ATE480620T1
Authority: AT; Austria
Prior art keywords: pgc; nucleic acid; acid molecules; expression vectors; isoforms
Prior art date: 2001-07-05

Application number

AT02749811T

Other languages

English (en)

Inventor

Bruce Spiegelman

Guillaume Adelmant

Pere Puigserver

Original Assignee

Dana Farber Cancer Inst Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-05

Filing date

2002-07-03

Publication date

2010-09-15

2002-07-03 Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc

2010-09-15 Application granted granted Critical

2010-09-15 Publication of ATE480620T1 publication Critical patent/ATE480620T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Diabetes (AREA)
Hematology (AREA)
Gastroenterology & Hepatology (AREA)
Obesity (AREA)
Physical Education & Sports Medicine (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Endocrinology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Orthopedic Medicine & Surgery (AREA)
Biochemistry (AREA)
Zoology (AREA)
Urology & Nephrology (AREA)
Rheumatology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Child & Adolescent Psychology (AREA)
Emergency Medicine (AREA)
Reproductive Health (AREA)
Neurology (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)

AT02749811T 2001-07-05 2002-07-03 Neue pgc-1-isoformen und deren verwendungen ATE480620T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US30346801P	2001-07-05	2001-07-05
PCT/US2002/021337 WO2003004613A2 (en)	2001-07-05	2002-07-03	Novel pgc-1 isoforms and uses therefor

Publications (1)

Publication Number	Publication Date
ATE480620T1 true ATE480620T1 (de)	2010-09-15

Family

ID=23172241

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02749811T ATE480620T1 (de)	2001-07-05	2002-07-03	Neue pgc-1-isoformen und deren verwendungen

Country Status (8)

Country	Link
US (2)	US7250283B2 (de)
EP (1)	EP1412374B1 (de)
JP (1)	JP4495961B2 (de)
AT (1)	ATE480620T1 (de)
AU (1)	AU2002320301A1 (de)
CA (1)	CA2451395C (de)
DE (1)	DE60237613D1 (de)
WO (1)	WO2003004613A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1513558A4 (de) *	2002-02-13	2005-11-23	Dana Farber Cancer Inst Inc	VERFAHREN UND ZUSAMMENSETZUNG ZUR MODULIERUNG DER TYP I MUSKELBILDUNG MIT PGC-1a-
JPWO2005093068A1 (ja) *	2004-03-29	2008-02-14	大日本住友製薬株式会社	新規タンパク質及びプロモーター
CA2572638A1 (en) *	2004-07-07	2006-02-09	Dana-Farber Cancer Institute, Inc.	Methods and compositions for treating obesity
US7989179B2 (en)	2005-06-28	2011-08-02	Daiichi Sankyo Company, Limited	LXR ligand testing method
WO2011035134A1 (en) *	2009-09-17	2011-03-24	The Ohio State University	Microdevices for implantation comprising thermogenic cells for treating a metabolic disease
US9044606B2 (en)	2010-01-22	2015-06-02	Ethicon Endo-Surgery, Inc.	Methods and devices for activating brown adipose tissue using electrical energy
US8476227B2 (en)	2010-01-22	2013-07-02	Ethicon Endo-Surgery, Inc.	Methods of activating a melanocortin-4 receptor pathway in obese subjects
US9937161B2 (en)	2013-03-06	2018-04-10	The General Hospital Corporation	Combinatorial compositions and methods for treatment of melanoma
US10092738B2 (en)	2014-12-29	2018-10-09	Ethicon Llc	Methods and devices for inhibiting nerves when activating brown adipose tissue
US10080884B2 (en)	2014-12-29	2018-09-25	Ethicon Llc	Methods and devices for activating brown adipose tissue using electrical energy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6426411B1 (en) *	1997-05-30	2002-07-30	Dana-Farber Cancer Institute	PGC-1, a novel brown fat pparγ coactivator
DE69836963T2 (de) *	1997-05-30	2007-10-25	Dana-Farber Cancer Institute, Boston	PGC-1, EIN NEUARTIGER PPAR-gamma-KOAKTIVATOR AUS BRAUNEM FETTGEWEBE
WO2001035096A2 (en) *	1999-11-10	2001-05-17	Mitokor	Diseases associated with altered mitochondrial function

2002
- 2002-07-03 EP EP02749811A patent/EP1412374B1/de not_active Expired - Lifetime
- 2002-07-03 US US10/482,094 patent/US7250283B2/en not_active Expired - Lifetime
- 2002-07-03 CA CA2451395A patent/CA2451395C/en not_active Expired - Lifetime
- 2002-07-03 DE DE60237613T patent/DE60237613D1/de not_active Expired - Lifetime
- 2002-07-03 AT AT02749811T patent/ATE480620T1/de not_active IP Right Cessation
- 2002-07-03 AU AU2002320301A patent/AU2002320301A1/en not_active Abandoned
- 2002-07-03 WO PCT/US2002/021337 patent/WO2003004613A2/en active Application Filing
- 2002-07-03 JP JP2003510772A patent/JP4495961B2/ja not_active Expired - Lifetime
2007
- 2007-06-20 US US11/765,855 patent/US20090098569A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2003004613A2 (en)	2003-01-16
JP4495961B2 (ja)	2010-07-07
CA2451395C (en)	2015-11-24
JP2004533842A (ja)	2004-11-11
EP1412374B1 (de)	2010-09-08
EP1412374A4 (de)	2005-07-20
AU2002320301A1 (en)	2003-01-21
US20040254362A1 (en)	2004-12-16
US7250283B2 (en)	2007-07-31
EP1412374A2 (de)	2004-04-28
CA2451395A1 (en)	2003-01-16
WO2003004613A3 (en)	2003-11-20
US20090098569A1 (en)	2009-04-16
DE60237613D1 (de)	2010-10-21

Publication	Publication Date	Title
FR19C1020I1 (fr)	2019-05-03	Nouvelles molecules b7-4 et leurs utilisations
DE60035517D1 (de)	2007-08-23	Gl50 moleküle, sowie verwendungen derselben
WO2003042362A3 (en)	2005-03-03	PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR
ATE480620T1 (de)	2010-09-15	Neue pgc-1-isoformen und deren verwendungen
WO2001087978A3 (en)	2002-05-30	Human abc transporter and its use
WO2002103015A3 (en)	2003-09-18	Abca10 transporter
DE60142356D1 (de)	2010-07-22	18480 humane proteinkinasemoleküle und ihre verwendungen
WO2002016591A3 (en)	2003-06-26	Human transporter family members and uses thereof
ATE433489T1 (de)	2009-06-15	16836, ein mitglied der humanen phospholipase c familie und seine verwendungen
WO2001014414A3 (en)	2001-07-19	Human abc2 transporter and uses thereof
DE60124910D1 (de)	2007-01-11	Menschliche twik-8 moleküle und ihre verwendung
DE60237236D1 (de)	2010-09-16	Ein mitglied der menschlichen proteinkinasefamilie, und verwendungen dafür
DE60136832D1 (de)	2009-01-15	Atcr-1, eine humane acyltransferase und verwendungen davon
DE60234047D1 (de)	2009-11-26	15603, ein mitglied der humanen ionenkanal-familie
WO2003035840A3 (en)	2004-02-26	69583 and 85924, novel human protein kinase family members and uses therefor
WO2002010401A3 (en)	2003-03-06	18431 and 32374, human protein kinase family members and uses therefor
WO2002070690A3 (en)	2003-01-16	Abca5 transporter and uses thereof
WO2002070693A3 (en)	2003-03-13	Novel abca6 transporter and uses thereof
DE60120974D1 (de)	2006-08-03	Proteinkinase-molekül 14911 und dessen anwendungen
WO2002070692A3 (en)	2003-04-10	Abca9 transporter and uses thereof
WO2002076174A3 (en)	2002-11-14	Fbh58295fl, a novel human amino acid transporter and uses thereof
WO2002002602A3 (en)	2002-08-22	Slgp protein and nucleic acid molecules and uses therefor
WO2003025200A3 (en)	2004-12-29	Methods of using 22417, a novel human aminoprotease family member

Legal Events

Date	Code	Title	Description
2011-03-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties